当前位置:首页 - 行情中心 - 奥泰生物(688606) - 财务分析 - 现金流量表

奥泰生物

(688606)

  

流通市值:54.09亿  总市值:54.09亿
流通股本:7928.09万   总股本:7928.09万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金603,168,086.39406,781,612.87193,359,376.05859,931,172.4
  收到的税费返还26,364,742.6522,560,355.2517,860,430.5933,478,859.02
  收到其他与经营活动有关的现金42,242,732.7321,636,906.427,701,470.5153,857,468.69
  经营活动现金流入小计671,775,561.77450,978,874.54218,921,277.15947,267,500.11
  购买商品、接受劳务支付的现金271,454,439.49196,560,468.32100,884,381.32329,344,035.42
  支付给职工以及为职工支付的现金146,583,141.2890,667,788.3657,491,839.02164,926,948.6
  支付的各项税费29,385,705.7423,025,629.449,212,432.8841,587,954.87
  支付其他与经营活动有关的现金109,892,673.2779,371,352.6740,587,433.7681,886,688.17
  经营活动现金流出小计557,315,959.78389,625,238.79208,176,086.98617,745,627.06
  经营活动产生的现金流量净额114,459,601.9961,353,635.7510,745,190.17329,521,873.05
二、投资活动产生的现金流量:
  收回投资收到的现金1,625,959,726.121,323,366,810.53587,869,728.522,397,202,827.21
  取得投资收益收到的现金9,159,557.797,053,526.66599,952.146,973,967.54
  处置固定资产、无形资产和其他长期资产收回的现金净额6,866,995.119,799,934.0411,138,211.141,690,718.96
  收到的其他与投资活动有关的现金20,000,000---
  投资活动现金流入小计1,661,986,279.021,340,220,271.23599,607,891.82,405,867,513.71
  购建固定资产、无形资产和其他长期资产支付的现金158,771,492.08120,754,290.2583,890,501.26220,654,916.2
  投资支付的现金1,423,303,120.96973,386,622.12550,201,994.752,644,268,000
  支付其他与投资活动有关的现金---20,000,000
  投资活动现金流出小计1,582,074,613.041,094,140,912.37634,092,496.012,884,922,916.2
  投资活动产生的现金流量净额79,911,665.98246,079,358.86-34,484,604.21-479,055,402.49
三、筹资活动产生的现金流量:
  吸收投资收到的现金-3,396.29-401,425.36
  其中:子公司吸收少数股东投资收到的现金-3,396.29-401,425.36
  收到其他与筹资活动有关的现金10,357,453.01--8,571,353.34
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计10,357,453.013,396.29-8,972,778.7
  分配股利、利润或偿付利息支付的现金116,798,446.33116,801,088.61-232,661,896.77
  支付其他与筹资活动有关的现金1,878,977.471,342,278.99-49,043,939.34
  筹资活动现金流出平衡项目00-0
  筹资活动现金流出小计118,677,423.8118,143,367.6-281,705,836.11
  筹资活动产生的现金流量净额平衡项目00-0
  筹资活动产生的现金流量净额-108,319,970.79-118,139,971.31--272,733,057.41
四、汇率变动对现金及现金等价物的影响-5,492,523.53-630,750.5-365,488.395,978,316.56
五、现金及现金等价物净增加额80,558,773.65188,662,272.8-24,104,902.43-416,288,270.29
  加:期初现金及现金等价物余额900,336,955.59900,336,955.59900,336,955.591,316,625,225.88
  期末现金及现金等价物余额980,895,729.241,088,999,228.39876,232,053.16900,336,955.59
补充资料:
  净利润-132,101,804.86-302,909,852.72
  资产减值准备-608,005.17-9,071,584.44
  固定资产和投资性房地产折旧-14,984,686.14-24,652,445.76
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,984,686.14--
  无形资产摊销-695,669.45-1,186,703.61
  长期待摊费用摊销-3,381,437.94-10,283,495.12
  处置固定资产、无形资产和其他长期资产的损失----1,224,694.32
  固定资产报废损失-2,712.14-8,472.75
  公允价值变动损失--15,823,882.7--35,548,454.9
  财务费用-108,215.33--2,165,993.94
  投资损失--6,084,326.45--12,194,620.55
  递延所得税--3,083,990.79-7,982,279.95
  其中:递延所得税资产减少--3,072,716.68-7,971,005.84
    递延所得税负债增加--11,274.11-11,274.11
  存货的减少--6,893,892.49-19,264,533.53
  经营性应收项目的减少--40,221,876.2--52,124,402.69
  经营性应付项目的增加--32,616,589.87-28,912,450.05
  其他-9,199,135.78-14,228,102.2
  不涉及现金收支的投资和筹资活动金额其他项目---0
  现金的期末余额-1,088,999,228.39-900,336,955.59
  减:现金的期初余额-900,336,955.59-1,316,625,225.88
  现金及现金等价物的净增加额-188,662,272.8--416,288,270.29
公告日期2025-10-312025-08-302025-04-292025-04-29
审计意见(境内)标准无保留意见
TOP↑